UNSPSC 51192009: Halofenate

This classification denotes a uricosuric agent and anti-lipidemic agent with the molecular formula C19H17ClF3NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K9TZK4MNO6, chemically known as (p-chlorophenyl)((alpha,alpha,alpha-trifluoro-m-tolyl)oxy)acetic acid ester with n-(2-hydroxyethyl)acetamide but generally known as halofenate, which bears US NIH Compound Identifier 33584. European Medicines Agency schedules Halofenate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07999MIG.

UNSPSC 51192009 Halofenate is a Commodity code that does not map to the recent state and local contract opportunities posted under it. The three opportunities in the current block cover athletic training services for a municipal fire and police department (City of Tucson, RFP 260163, due June 9, 2026), medical aid supplies including first-aid kits and pain relievers for a fire rescue department (City of Tampa, ITB 25-P-00157, due April 9, 2025), and a Request for Information from the Texas Health and Human Services Commission regarding direct-to-manufacturer prescription programs. None of these solicitations involve halofenate, a pharmaceutical product; the code shows little relevant recent activity in state and local procurement.

The mismatch between the UNSPSC code's pharmaceutical scope and the opportunities tagged to it suggests a data-classification error rather than active procurement under the commodity itself. Halofenate procurement, if it occurs in state and local health systems, would more likely appear under pharmacy benefit management, bulk pharmaceutical procurement, or medical supply codes rather than under athletic training, first-aid supplies, or specialty prescription programs. Business development professionals should treat this code as inactive for current state and local opportunity purposes unless future postings correct the tagging.